Investor Resources

This Investor Centre resources section provides information for our securityholders and those considering becoming a securityholder. 

ASX Releases


Reporting Suite


Annual Reports


Annual General Meeting Information


Investor Days


Investor Resources


NAV Splits

Analyst Coverage


Research houseAnalyst
BarrenjoeyMatt Ryan
CitiSuraj Nebhani
Evans and PartnersCameron McDonald
Insight Investment ResearchRobert Crimes
JefferiesAnthony Moulder
Macquarie ResearchIan Myles
Morgan StanleyRob Koh
MorgansNathan Lead
Morningstar Equity ResearchAdrian Atkins
RBCOwen Birrell
UBSAndre Fromyhr

 

Atlas Arteria Limited and Atlas Arteria International Limited together with their controlled entities (Atlas Arteria Group) are followed by a number of research houses and analysts, including those listed above (Brokers). This list is provided for information only. Our publishing this list does not constitute a recommendation, confirmation or endorsement by any member of the Atlas Arteria Group, their directors, employees or representatives, of any of the opinions, estimates, forecasts, predictions, conclusions, recommendations, statements or representations, contained in any report a Broker may produce (Broker Report). All Broker Reports are published by and contain the information, opinions and predictions of the relevant Broker. Investors and other third parties should be aware that Broker Reports may contain errors, assumptions or omissions. Neither the Atlas Arteria Group nor its directors or employees give any assurance or warranty or otherwise represent that any Broker Report is accurate, true, complete, correct, current or otherwise free from error. Neither the Atlas Arteria Group, nor any of their directors or employees undertake or accept any obligation to review, update or correct anything in any Broker Report.

Frequently Asked Questions


How do I invest in Atlas Arteria securities?
Why did Macquarie Atlas change its name to Atlas Arteria?
What is a stapled security?
Why does ALX invest only in businesses outside Australia?
How does ALX manage its exposure to interest rate movements?
Can I reinvest my distribution?
What is the Australian Tax Office’s view of stapled securities?
I was formerly a MIG investor and received Atlas Arteria securities as a result of the demerger. What is my cost base in Atlas Arteria for capital gains tax?
How do I change my address or bank details?
What are the contact details for the registry?
When did Atlas Arteria list?
Is Atlas Arteria listed on any other stock exchange?
Why use a stapled security structure?
What is Atlas Arteria’s distribution policy?
Does Atlas Arteria send out annual tax statements?
How do I apportion the Atlas Arteria (ALX) share price between ATLAX and ATLIX?
I have been asked to confirm my Tax Residency, what do I need to do and why?
How can I choose to receive investor communications electronically?
Implications of the US ownership restrictions for US investors?

Contact ALX Investor Relations

Atlas Arteria (ALX) comprises Atlas Arteria Limited (ACN 141 075 201) (ATLAX) an Australian public company and Atlas Arteria International Limited (Registration No. 43828) (ATLIX), an exempted mutual fund company incorporated in Bermuda.

The information on this website has been prepared by ALX based on information available to them.  No representation or warranty, express or implied, is made as to the fairness, accuracy, completeness or correctness of the information, opinions and conclusions contained in this presentation.  To the maximum extent permitted by law, none of ATLAX, ATLIX, their directors, employees or agents, nor any other person accepts any liability for any loss arising from the use of this website or its contents or otherwise arising in connection with it, including, without limitation, any liability arising from fault or negligence on the part of ATLAX, ATLIX, or their directors, employees or agents.

None of the information on this website should be reproduced or distributed to any other party without the consent of ALX.

General Securities Warning

The information on this website is a general description of ALX and is not an offer or invitation for subscription or purchase of or a recommendation of securities.  If does not take into account the investment objectives, financial situation and particular needs of the investor.  Before making an investment in ALX the investor or prospective investor should consider whether such an investment is appropriate to their particular investment needs, objectives and financial circumstances and seek professional independent advice.

All securities and financial product or instrument transactions involve risks.  Past performance of ALX is not a reliable indication of future performance.